Ahn Dong Ki, Shin Won Shik, Kim Go We, Koo Ki Hyuk
Department of Orthopedic Surgery, Seoul Sacred Heart General Hospital, Seoul, Korea.
Asian Spine J. 2017 Dec;11(6):898-902. doi: 10.4184/asj.2017.11.6.898. Epub 2017 Dec 7.
Retrospective case-control study.
To examine the hypothesis that the misuse of thrombin-containing local hemostatics (TCLH) increases the risk of postoperative spinal epidural hematoma (POSEH).
Many studies have focused on hypocoagulability as a risk factor for POSEH. However, there are no prior reports on the increased risk of POSEH in hypercoagulable states.
Posterior instrumented lumbar spine surgery cases over 2 consecutive years were divided into two groups: a study group (98 patients in whom TCLH was used) and a control group (176 patients in whom TCLH was not used). The excess TCLH matrix that was not associated with blood clot was not removed from the patients in the study group. The senior author decided whether to use TCLH or not. Suction drains were used in all patients. The demographics, coagulation-related factors, and intraoperative factors of the patients in the two groups were analyzed. The development of POSEH was compared between the two groups.
The two groups were homogenous in demographics (age and sex), coagulation-related factors (platelet count, prothrombin time, activated partial thromboplastin time, and platelet function analysis), and surgical factors (total blood loss, operation time, blood loss/10 minutes, number of fusion segments, posterolateral fusion/posterior lumbar interbody fusion, and virgin or revision surgery). POSEH developed more frequently in the patients in the study group than in those in the control group (14/98 patients, 14.3% vs. 3/176 patients, 1.7%, respectively; =0.001; odds ratio, 17.1).
TCLH causes blood clot not only at the edge of damaged vessels but also at the site of extravascular blood. Excess TCLH matrix not associated with blood clot at the epidural space can enhance POSEH development because early clotted hematomas do not drain through suction drains.
回顾性病例对照研究。
检验含凝血酶局部止血剂(TCLH)的不当使用会增加术后脊髓硬膜外血肿(POSEH)风险这一假设。
许多研究聚焦于低凝状态作为POSEH的一个风险因素。然而,此前尚无关于高凝状态下POSEH风险增加的报道。
连续两年的后路腰椎器械手术病例被分为两组:研究组(98例使用TCLH的患者)和对照组(176例未使用TCLH的患者)。研究组患者未清除与血凝块无关的多余TCLH基质。由资深作者决定是否使用TCLH。所有患者均使用吸引引流管。分析两组患者的人口统计学、凝血相关因素和术中因素。比较两组POSEH的发生情况。
两组在人口统计学(年龄和性别)、凝血相关因素(血小板计数、凝血酶原时间、活化部分凝血活酶时间和血小板功能分析)以及手术因素(总失血量、手术时间、每10分钟失血量、融合节段数、后外侧融合/后路腰椎椎间融合以及初次或翻修手术)方面具有同质性。研究组患者中POSEH的发生比对照组更频繁(分别为14/98例患者,14.3% 对3/176例患者,1.7%;P = 0.001;优势比,17.1)。
TCLH不仅会在受损血管边缘形成血凝块,还会在血管外血液部位形成血凝块。硬膜外间隙与血凝块无关的多余TCLH基质可促进POSEH的发生,因为早期形成的血凝块不会通过吸引引流管排出。